Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Best of the Month: Salaries on the rise | Frustrated surgeons | Private equity in the spotlight | Diabetes drug & sleep apnea
Monday, July 1, 2024
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

The Month in Review

Editor's Note:

Our most popular stories for the month of June highlight some of the biggest issues impacting today’s healthcare providers. Salaries continue to rise, for example, though they are climbing much more for some specialties than others. We also learned that surgeons are frustrated by the use of outdated technology in their operating rooms. If health systems don’t start investing in more new equipment, could an exodus of sorts be on the horizon? Another top story examined the rising influence of private equity in healthcare. The FTC asked stakeholders to share their opinions about this trend, and the public comments suggest many are not yet on board.

That’s just a small taste of what we explored last month. I’m excited to see what July will bring. As always, thank you for reading. | Michael Walter - Editor

Editor's Note:

Our most popular stories for the month of June highlight some of the biggest issues impacting today’s healthcare providers. Salaries continue to rise, for example, though they are climbing much more for some specialties than others. We also learned that surgeons are frustrated by the use of outdated technology in their operating rooms. If health systems don’t start investing in more new equipment, could an exodus of sorts be on the horizon? Another top story examined the rising influence of private equity in healthcare. The FTC asked stakeholders to share their opinions about this trend, and the public comments suggest many are not yet on board. That’s just a small taste of what we explored last month. I’m excited to see what July will bring. As always, thank you for reading. | Michael Walter - Editor

Cardiology salaries keep rising, outpacing consumer prices—interventional cardiologists see biggest jump

Cardiology's gains are far less than some specialties—pay for dermatologists went up more than 10%, for instance—but still ahead of the consumer price index.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

Cardiology salaries keep rising, outpacing consumer prices—interventional cardiologists see biggest jump

Share on Twitter Share on Facebook Share on Linkedin
women doctors
Cardiology's gains are far less than some specialties—pay for dermatologists went up more than 10%, for instance—but still ahead of the consumer price index.
READ MORE >

Heart surgeons are fed up with old technology—many have considered a career change

A majority of U.S. surgeons, including those who treat heart patients on a daily basis, say their operating rooms use outdated technology. It is having a negative impact on patient care. 

READ MORE >
The Anesthesia Patient Safety Foundation (APSF), a related organization of the American Society of Anesthesiologists (ASA), this week released a statement on the criminalization of medical errors. The APSF said criminal prosecution is unjust and counterproductive is healthcare organizations want to find ways to mitigate errors by understanding how they happen and create protocols or IT systems can can help prevent future errors. The criminal trial of nurse RaDonda Vaught was counterproductive to safety.
Share on Twitter Share on Facebook Share on Linkedin

Heart surgeons are fed up with old technology—many have considered a career change

Share on Twitter Share on Facebook Share on Linkedin
The Anesthesia Patient Safety Foundation (APSF), a related organization of the American Society of Anesthesiologists (ASA), this week released a statement on the criminalization of medical errors. The APSF said criminal prosecution is unjust and counterproductive is healthcare organizations want to find ways to mitigate errors by understanding how they happen and create protocols or IT systems can can help prevent future errors. The criminal trial of nurse RaDonda Vaught was counterproductive to safety.
A majority of U.S. surgeons, including those who treat heart patients on a daily basis, say their operating rooms use outdated technology. It is having a negative impact on patient care. 
READ MORE >

Private equity in healthcare: Cardiologists, government officials and advocacy groups share their perspective

The FTC and other federal agencies launched a public inquiry to see how physicians, patients and other stakeholders felt about the rising influence of private equity in healthcare. Based on the public comments available online, many in the industry are concerned about the trend's long-term impact on patient care. 

READ MORE >
healthcare money economics dollar stethoscope acquire merger
Share on Twitter Share on Facebook Share on Linkedin

Private equity in healthcare: Cardiologists, government officials and advocacy groups share their perspective

Share on Twitter Share on Facebook Share on Linkedin
healthcare money economics dollar stethoscope acquire merger
The FTC and other federal agencies launched a public inquiry to see how physicians, patients and other stakeholders felt about the rising influence of private equity in healthcare. Based on the public comments available online, many in the industry are concerned about the trend's long-term impact on patient care. 
READ MORE >

First large-scale studies of wearable ambulatory cardiac monitoring shed light on usage 

Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.

READ MORE >
Video interview with Matthew Reynolds, MD, who shares data on largest wearable ambulatory cardiac monitoring studies to date from the EXCALIBER and CAMELOT trials at HRS 2024. #HRS #HRS2024 #Remotemonitoring
Share on Twitter Share on Facebook Share on Linkedin

First large-scale studies of wearable ambulatory cardiac monitoring shed light on usage 

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Matthew Reynolds, MD, who shares data on largest wearable ambulatory cardiac monitoring studies to date from the EXCALIBER and CAMELOT trials at HRS 2024. #HRS #HRS2024 #Remotemonitoring
Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.
READ MORE >

New 5:2 intermittent fasting diet bests metformin, empagliflozin in patients with early-stage type 2 diabetes

The new-look diet was linked to significant weight loss and reductions in HbA1C levels. Researchers see it as a potential alternative to immediately putting patients on new medications. 

READ MORE >
5:2 intermittent fasting diet
Share on Twitter Share on Facebook Share on Linkedin

New 5:2 intermittent fasting diet bests metformin, empagliflozin in patients with early-stage type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
5:2 intermittent fasting diet
The new-look diet was linked to significant weight loss and reductions in HbA1C levels. Researchers see it as a potential alternative to immediately putting patients on new medications. 
READ MORE >

Edwards Lifesciences sells critical care business to BD for $4.2B—remains ‘laser focused’ on structural heart disease

This move represents a pivot of sorts for Edwards; instead of pursuing a spin-off of its critical care business, the company is now doubling down on its commitment to develop new structural heart technologies. BD, meanwhile, says the transaction will deliver significant value. 

READ MORE >
Healthcare M&A, mergers and acquisitions business deal.
Share on Twitter Share on Facebook Share on Linkedin

Edwards Lifesciences sells critical care business to BD for $4.2B—remains ‘laser focused’ on structural heart disease

Share on Twitter Share on Facebook Share on Linkedin
Healthcare M&A, mergers and acquisitions business deal.
This move represents a pivot of sorts for Edwards; instead of pursuing a spin-off of its critical care business, the company is now doubling down on its commitment to develop new structural heart technologies. BD, meanwhile, says the transaction will deliver significant value. 
READ MORE >

Energy drinks and sudden cardiac arrest: There’s smoke, and there may be fire

Individuals with underlying heart disease may want to avoid energy drinks going forward, according to a new Mayo Clinic analysis.

READ MORE >
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.
Share on Twitter Share on Facebook Share on Linkedin

Energy drinks and sudden cardiac arrest: There’s smoke, and there may be fire

Share on Twitter Share on Facebook Share on Linkedin
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.
Individuals with underlying heart disease may want to avoid energy drinks going forward, according to a new Mayo Clinic analysis.
READ MORE >

New-look polymer mitral valve linked to positive outcomes 30 days after surgery

The new surgical valve from Foldax was designed to limit calcification and make it so patients do not require long-term anticoagulant therapy following treatment. 

READ MORE >
The Tria surgical mitral valve is built using LifePolymer, a proprietary material that does not include animal tissue. Both the frame of the valve and its leaflets are generated by computer to match each patient’s native mitral valve. According to Foldax, this new-look polymer reduces the long-term risk of valve calcification, and patients should be able to bounce back after surgery without requiring the long-time use of anticoagulants.
Share on Twitter Share on Facebook Share on Linkedin

New-look polymer mitral valve linked to positive outcomes 30 days after surgery

Share on Twitter Share on Facebook Share on Linkedin
The Tria surgical mitral valve is built using LifePolymer, a proprietary material that does not include animal tissue. Both the frame of the valve and its leaflets are generated by computer to match each patient’s native mitral valve. According to Foldax, this new-look polymer reduces the long-term risk of valve calcification, and patients should be able to bounce back after surgery without requiring the long-time use of anticoagulants.
The new surgical valve from Foldax was designed to limit calcification and make it so patients do not require long-term anticoagulant therapy following treatment. 
READ MORE >

Medtronic TAVR valves at heart of multiple sessions during New York cardiology conference

Medtronic’s TAVR technology received a significant amount of attention during the very first New York Valves conference in New York City. Research focused on patients with small annuli as well as how five-year outcomes compare to surgery. 

READ MORE >
Medtronic CoreValve Evolut TAVR device in the Medtronic booth at TCT 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Medtronic TAVR valves at heart of multiple sessions during New York cardiology conference

Share on Twitter Share on Facebook Share on Linkedin
Medtronic CoreValve Evolut TAVR device in the Medtronic booth at TCT 2023. Photo by Dave Fornell
Medtronic’s TAVR technology received a significant amount of attention during the very first New York Valves conference in New York City. Research focused on patients with small annuli as well as how five-year outcomes compare to surgery. 
READ MORE >

Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards?

Based on positive results from two different trials, Eli Lilly and Company hopes to secure a new FDA approval for tirzepatide in the months ahead.

READ MORE >
tirzepatide injections Zepbound Eli Lilly. The U.S. Food and Drug Administration (FDA) cleared Eli Lilly and Company’s tirzepatide injections for chronic weight management in adult patients who are obese, overweight or present with at least one weight-related condition such as high blood pressure or high cholesterol. These weekly injections are being sold and distributed under the brand name Zepbound. Tirzepatide is also used in Mounjaro, FDA cleared in 2022 for improving glycemic control in adults.
Share on Twitter Share on Facebook Share on Linkedin

Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards?

Share on Twitter Share on Facebook Share on Linkedin
tirzepatide injections Zepbound Eli Lilly. The U.S. Food and Drug Administration (FDA) cleared Eli Lilly and Company’s tirzepatide injections for chronic weight management in adult patients who are obese, overweight or present with at least one weight-related condition such as high blood pressure or high cholesterol. These weekly injections are being sold and distributed under the brand name Zepbound. Tirzepatide is also used in Mounjaro, FDA cleared in 2022 for improving glycemic control in adults.
Based on positive results from two different trials, Eli Lilly and Company hopes to secure a new FDA approval for tirzepatide in the months ahead.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis
Shockwave Medical's new IVL catheter | BATMAN to the rescue | Antiplatelet drugs after PCI | FDA announces recalls
When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more
TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Page 4
    • Current page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup